HuGE Literature Finder
Records 1-49
|
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients.
British journal of haematology 2018 Aug . Macauda Angelica, Castelli Eleonora, Buda Gabriele, Pelosini Matteo, Butrym Aleksandra, Watek Marzena, Kruszewski Marcin, Vangsted Annette Juul, Rymko Marcin, Jamroziak Krzysztof, Abildgaard Niels, Haastrup Eva Kannik, Mazur Grzegorz, Ríos Rafael, Jurczyszyn Artur, Zawirska Daria, Dudzi?ski Marek, Ra?ny Ma?gorzata, Dutka Magdalena, Tomczak Waldemar, Suska Anna, Druzd-Sitek Agnieszka, Marques Herlander, Petrini Mario, Markiewicz Miroslaw, Martinez-Lopez Joaquin, Ebbesen Lene Hyldahl, Iskierka-Ja?d?ewska El?bieta, Sainz Juan, Canzian Federico, Campa Danie |
|
Effects of polymorphisms in NR1I2, CYP3A4, and ABC transporters on the steady-state plasma trough concentrations of bosutinib in Japanese patient with chronic myeloid leukemia.
Medical oncology (Northwood, London, England) 2018 May 35 (6): 90. Abumiya Maiko, Mita Akiko, Takahashi Saori, Yoshioka Tomoko, Kameoka Yoshihiro, Takahashi Naoto, Miura Masato |
|
Association between PXR polymorphisms and cancer risk: a systematic review and meta-analysis.
Bioscience reports 2018 Apr . Wen Jing, Lv Zhi, Ding Hanxi, Fang Xinxin, Sun Mingj |
|
Analysis of 12 variants in the development of gastric and colorectal cancers.
World journal of gastroenterology 2017 Dec 23 (48): 8533-8543. Cavalcante Giovanna C, Amador Marcos At, Ribeiro Dos Santos André M, Carvalho Darlen C, Andrade Roberta B, Pereira Esdras Eb, Fernandes Marianne R, Costa Danielle F, Santos Ney Pc, Assumpção Paulo P, Ribeiro Dos Santos Ândrea, Santos Sidn |
|
Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer.
Cancer chemotherapy and pharmacology 2017 Jul . Mbatchi Litaty C, Gassiot Matthieu, Pourquier Philippe, Goberna Alejando, Mahammedi Hakim, Mourey Loic, Joly Florence, Lumbroso Serge, Evrard Alexandre, Houede Nadi |
|
Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients.
International journal of molecular sciences 2017 Mar 18 (3): . Liu Jing, Chen Zhiyu, Chen Hanmei, Hou Yingyong, Lu Weiqi, He Junyi, Tong Hanxing, Zhou Yuhong, Cai Weim |
|
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.
Oncotarget 2016 Aug . Hegyi Marta, Arany Adam, Semsei Agnes F, Csordas Katalin, Eipel Oliver, Gezsi Andras, Kutszegi Nora, Csoka Monika, Muller Judit, Erdelyi Daniel J, Antal Peter, Szalai Csaba, Kovacs Gabor |
|
[Effect of polymorphisms of NF-?B and PXR on platinum-based chemotherapy for non-small cell lung cancer].
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2016 Mar 41 (3): 233-7. Zhou Yaxing, Yang Pei, Liu Yingzhi, Wang Lianshe |
|
Distribution of allelic and genotypic frequencies of IL1A, IL4, NFKB1 and PAR1 variants in Native American, African, European and Brazilian populations.
BMC research notes 2016 Feb 9 101. Amador Marcos A T, Cavalcante Giovanna C, Santos Ney P C, Gusmão Leonor, Guerreiro João F, Ribeiro-dos-Santos Ândrea, Santos Sidn |
|
Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients.
Clinical pharmacokinetics 2016 09 55 (9): 1145-57. Mbatchi Litaty Céphanoée, Robert Jacques, Ychou Marc, Boyer Jean-Christophe, Del Rio Maguy, Gassiot Matthieu, Thomas Fabienne, Tubiana Nicole, Evrard Alexand |
|
Functional variants inPXRare associated with colorectal cancer susceptibility in Chinese populations.
Cancer epidemiology 2015 Nov 39 (6): 972-977. Ni Haizhen, Su Bofeng, Pan Lemen, Li Xueyan, Zhu Xixia, Chen Xiangji |
|
Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma.
European journal of clinical pharmacology 2015 Sep . Diekstra Meta H M, Liu Xiaoyan, Swen Jesse J, Boven Epie, Castellano Daniel, Gelderblom Hans, Mathijssen Ron H J, Rodríguez-Antona Cristina, García-Donas Jesus, Rini Brian I, Guchelaar Henk-J |
|
The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
British journal of haematology 2015 Sep 170 (6): 847-58. Olsson Linda, Ivanov Öfverholm Ingegerd, Norén-Nyström Ulrika, Zachariadis Vasilios, Nordlund Jessica, Sjögren Helene, Golovleva Irina, Nordgren Ann, Paulsson Kajsa, Heyman Mats, Barbany Gisela, Johansson Bert |
|
Role of NR1I2 (pregnane X receptor) polymorphisms in head and neck squamous cell carcinoma.
Naunyn-Schmiedeberg's archives of pharmacology 2015 Jul . Reuter Tasmin, Warta Rolf, Theile Dirk, Meid Andreas D, Rigalli Juan Pablo, Mogler Carolin, Herpel Esther, Grabe Niels, Lahrmann Bernd, Plinkert Peter K, Herold-Mende Christel, Dyckhoff Gerhard, Haefeli Walter Emil, Weiss Johan |
|
Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients.
Investigational new drugs 2015 Feb 33 (1): 257-68. Narjoz C, Cessot A, Thomas-Schoemann A, Golmard J L, Huillard O, Boudou-Rouquette P, Behouche A, Taieb F, Durand J P, Dauphin A, Coriat R, Vidal M, Tod M, Alexandre J, Loriot M A, Goldwasser F, Blanchet |
|
Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXR? and HNF4?) on docetaxel disposition in Chinese nasopharyngeal cancer patients.
European journal of clinical pharmacology 2014 Feb 70 (2): 155-66. Chew Sin-Chi, Lim Joanne, Singh Onkar, Chen Xiangai, Tan Eng-Huat, Lee Edmund-J D, Chowbay Balr |
|
A functional polymorphism in the 3'-UTR of PXR interacts with smoking to increase lung cancer risk in southern and eastern Chinese smoker.
International journal of molecular sciences 2014 15 (10): 17457-68. Zhang Lisha, Qiu Fuman, Lu Xiaoxiao, Li Yinyan, Fang Wenxiang, Zhang Lan, Zhou Yifeng, Yang Lei, Lu Jiach |
|
The PXR rs7643645 polymorphism is associated with the risk of higher prostate-specific antigen levels in prostate cancer patients.
PloS one 2014 9 (6): e99974. Reyes-Hernández Octavio D, Vega Libia, Jiménez-Ríos Miguel A, Martínez-Cervera Pedro F, Lugo-García Juan A, Hernández-Cadena Leticia, Ostrosky-Wegman Patricia, Orozco Lorena, Elizondo Guiller |
|
The protease activated receptor 1 gene variation IVSn -14 A>T is associated with distant metastasis and cancer specific survival in renal cell carcinoma.
The Journal of urology 2013 Oct 190 (4): 1392-7. de Martino Michela, Haitel Andrea, Schatzl Georg, Klatte Tobi |
|
C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC.
Lung cancer (Amsterdam, Netherlands) 2013 Jul 81 (1): 123-9. Uzunoglu Faik Güntac, Yavari Neda, Bohn Benjamin Alexander, Nentwich Michael Fabian, Reeh Matthias, Pantel Klaus, Perez Daniel, Tsui Tung Yu, Bockhorn Maximilian, Mann Oliver, Izbicki Jakob Robert, Wikman Harriet, Vashist Yogesh Kum |
|
Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium.
Journal of human genetics 2013 Mar 58 (3): 155-9. Martino Alessandro, Sainz Juan, Manuel Reis Rui, Moreno Victor, Buda Gabriele, Lesueur Fabienne, Marques Herlander, García-Sanz Ramón, Ríos Rafael, Stein Angelika, Dumontet Charles, Gemignani Federica, Maria Rossi Anna, Landi Stefano, Jurado Manuel, Petrini Mario, Jamroziak Krzysztof, Campa Daniele, Canzian Federi |
|
Role of pharmacogenetics on adjuvant chemotherapy-induced neutropenia in Chinese breast cancer patients.
Journal of cancer research and clinical oncology 2013 Mar 139 (3): 419-27. Tang Nelson L S, Liao Chen Di, Wang Xingyan, Mo Frankie K F, Chan Vicky T C, Ng Rita, Pang Elizabeth, Suen Joyce J S, Woo Jean, Yeo Winn |
|
VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Jan . Uzunoglu FG, Kolbe J, Wikman H, Güngör C, Bohn BA, Nentwich MF, Reeh M, König AM, Bockhorn M, Kutup A, Mann O, Izbicki JR, Vashist YK |
|
PAR-1 polymorphisms and risk of Helicobacter pylori-related gastric cancer in a Chinese population.
Anticancer research 2012 Sep 32 (9): 3715-21. Castaño-Rodríguez Natalia, Kaakoush Nadeem O, Goh Khean-Lee, Fock Kwong Ming, Chionh Yok Teng, Sutton Philip, Mitchell Hazel |
|
A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.
International journal of cancer. Journal international du cancer 2012 Aug 131 (4): 803-12. Campa Daniele, Butterbach Katja, Slager Susan L, Skibola Christine F, de Sanjosé Silvia, Benavente Yolanda, Becker Nikolaus, Foretova Lenka, Maynadie Marc, Cocco Pierluigi, Staines Anthony, Kaaks Rudolf, Boffetta Paolo, Brennan Paul, Conde Lucia, Bracci Paige M, Caporaso Neil E, Strom Sara S, Camp Nicola J, Cerhan James R, Consortium Gec, Canzian Federico, Nieters Alexand |
|
The association of protease activated receptor 1 gene -506 I/D polymorphism with disease-free survival in breast cancer patients.
Annals of surgical oncology 2012 Apr 19 (4): 1365-9. Ero?lu Aydan, Karab?y?k Afife, Akar Nej |
|
Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk.
Thyroid : official journal of the American Thyroid Association 2012 Feb 22 (2): 151-6. Schonfeld Sara J, Neta Gila, Sturgis Erich M, Pfeiffer Ruth M, Hutchinson Amy A, Xu Li, Wheeler William, Guénel Pascal, Rajaraman Preetha, de Vathaire Florent, Ron Elaine, Tucker Margaret A, Chanock Stephen J, Sigurdson Alice J, Brenner Alina |
|
Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer.
Pharmacogenetics and genomics 2011 Oct 21 (10): 615-23. Koutros Stella, Andreotti Gabriella, Berndt Sonja I, Hughes Barry Kathryn, Lubin Jay H, Hoppin Jane A, Kamel Freya, Sandler Dale P, Burdette Laurie A, Yuenger Jeffrey, Yeager Meredith, Alavanja Michael C R, Freeman Laura E Bea |
|
Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide.
Leukemia research 2011 Sep 35 (9): 1178-83. Cibeira María Teresa, de Larrea Carlos Fernández, Navarro Alfons, Díaz Tania, Fuster Dolors, Tovar Natalia, Rosiñol Laura, Monzó Mariano, Bladé Jo |
|
Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
Endocrine-related cancer 2011 Jun 18 (3): 371-84. Rudolph Anja, Sainz Juan, Hein Rebecca, Hoffmeister Michael, Frank Bernd, Försti Asta, Brenner Hermann, Hemminki Kari, Chang-Claude Jen |
|
Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Jun 29 (18): 2557-64. Xu Chun-Fang, Bing Nan X, Ball Howard A, Rajagopalan Dilip, Sternberg Cora N, Hutson Thomas E, de Souza Paul, Xue Zhengyu G, McCann Lauren, King Karen S, Ragone Leigh J, Whittaker John C, Spraggs Colin F, Cardon Lon R, Mooser Vincent E, Pandite Lini |
|
Protease activated receptor 1 gene -506 I?/?D polymorphism in cancer patients with and without venous thrombosis.
European journal of haematology 2011 Jun 86 (6): 546-7. Karab?y?k Afife, Ero?lu Aydan, Akar Nej |
|
Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
Endocrine-related cancer 2011 Apr 18 (2): 265-76. Sainz J, Rudolph A, Hein R, Hoffmeister M, Buch S, von Schönfels W, Hampe J, Schafmayer C, Völzke H, Frank B, Brenner H, Försti A, Hemminki K, Chang-Claude |
|
Genetic polymorphisms associated with a prolonged progression-free survival in patients with metastatic renal cell cancer treated with sunitinib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Feb 17 (3): 620-9. van der Veldt Astrid A M, Eechoute Karel, Gelderblom Hans, Gietema Jourik, Guchelaar Henk-Jan, van Erp Nielka P, van den Eertwegh Alfons J M, Haanen John B, Mathijssen Ron H J, Wessels Judith A |
|
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk.
Breast cancer research and treatment 2011 Jan 125 (2): 563-9. Justenhoven Christina, Schaeffeler Elke, Winter Stefan, Baisch Christian, Hamann Ute, Harth Volker, Rabstein Sylvia, Spickenheuer Anne, Pesch Beate, Brüning Thomas, Ko Yon-Dschun, Schwab Matthias, Brauch Hiltr |
|
Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma.
BMC gastroenterology 2011 11 (1): 108. van de Winkel Anouk, Menke Vivianda, Capello Astrid, Moons Leon M G, Pot Raymond G J, van Dekken Herman, Siersema Peter D, Kusters Johannes G, van der Laan Luc J W, Kuipers Ernst |
|
MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer.
Carcinogenesis 2010 Dec 31 (12): 2118-23. Zhang Xiaofan, Yang Hushan, Lee J Jack, Kim Edward, Lippman Scott M, Khuri Fadlo R, Spitz Margaret R, Lotan Reuben, Hong Waun K, Wu Xife |
|
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
International journal of cancer. Journal international du cancer 2010 Jun 126 (12): 2935-46. Authors are not available |
|
Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus.
Annals of surgery 2010 May 251 (5): 857-64. Lurje Georg, Leers Jessica M, Pohl Alexandra, Oezcelik Arzu, Zhang Wu, Ayazi Shahin, Winder Thomas, Ning Yan, Yang Dongyun, Klipfel Nancy E, Chandrasoma Parakrama, Hagen Jeffrey A, DeMeester Steven R, DeMeester Tom R, Lenz Heinz-Jos |
|
Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010 Jan 21 (1): 78-86. Lurje G, Husain H, Power D G, Yang D, Groshen S, Pohl A, Zhang W, Ning Y, Manegold P C, El-Khoueiry A, Iqbal S, Tang L H, Shah M A, Lenz H |
|
Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes.
BMC cancer 2010 10 (1): 484. Andersen Vibeke, Christensen Jane, Overvad Kim, Tjønneland Anne, Vogel Ul |
|
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Jul 27 (21): 3540-6. Gandara David R, Kawaguchi Tomoya, Crowley John, Moon James, Furuse Kiyoyuki, Kawahara Masaaki, Teramukai Satoshi, Ohe Yuichiro, Kubota Kaoru, Williamson Stephen K, Gautschi Oliver, Lenz Heinz Josef, McLeod Howard L, Lara Primo N, Coltman Charles Arthur, Fukuoka Masahiro, Saijo Nagahiro, Fukushima Masanori, Mack Philip |
|
Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Jan 18 (1): 255-9. Mavaddat Nasim, Dunning Alison M, Ponder Bruce A J, Easton Douglas F, Pharoah Paul |
|
PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Nov 14 (21): 7116-26. Sandanaraj Edwin, Lal Suman, Selvarajan Viknesvaran, Ooi London Lucien, Wong Zee Wan, Wong Nan Soon, Ang Peter Cher Siang, Lee Edmund J D, Chowbay Balr |
|
PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients.
The pharmacogenomics journal 2008 Apr 8 (2): 139-46. Hor S Y, Lee S C, Wong C I, Lim Y W, Lim R C, Wang L Z, Fan L, Guo J Y, Lee H S, Goh B C, Tan |
|
Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4alpha, and constitutive androstane receptor with docetaxel pharmacokinetics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Dec 13 (23): 7126-32. Tham Lai-San, Holford Nicholas H G, Hor Sok-Ying, Tan Theresa, Wang Lingzhi, Lim Rui-Chen, Lee How-Sung, Lee Soo-Chin, Goh Boon-Ch |
|
Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Sep 25 (25): 3837-45. Lim Hyeong-Seok, Ju Lee Han, Seok Lee Keun, Sook Lee Eun, Jang In-Jin, Ro Jungs |
|
Identification of NR1I2 genetic variation using resequencing.
European journal of clinical pharmacology 2007 Jun 63 (6): 547-54. King Cristi R, Xiao Ming, Yu Jinsheng, Minton Matthew R, Addleman Nicholas J, Van Booven Derek J, Kwok Pui-Yan, McLeod Howard L, Marsh Shar |
|
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.
Blood 2006 Jun 107 (12): 4871-9. Monzo Mariano, Brunet Salut, Urbano-Ispizua Alvaro, Navarro Alfons, Perea Granada, Esteve Jordi, Artells Rosa, Granell Miquel, Berlanga Juan, Ribera Josep M, Bueno Javier, Llorente Andreu, Guardia Ramon, Tormo Mar, Torres Pio, Nomdedéu Josep F, Montserrat Emili, Sierra Jordi, |
- Page last reviewed:Jul 30, 2019
- Page last updated:Jan 16, 2020
- Content source: